M Konishi
Yamaguchi University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by M Konishi.
Immunology Letters | 1994
Masahiro Tsuchida; M Konishi; Kazutaka Jojima; Katsusuke Naito; Yoshihisa Fujikura; Tetsuo Fukumoto
The effects of glucocorticoid (GC) on thymocytes have been utilized to investigate the maturation and differentiation of thymocytes, but these experiments have mainly been performed on mouse thymocytes. We investigated the cell surface antigens expressed by LEW rat thymocytes during thymic reconstitution after GC treatment. Three-color flow cytofluorometric analysis of CD4, CD8 and the T cell antigen receptor (TCR alpha beta) clearly demonstrated that normal rat thymocytes contain CD4-8+ TCR alpha beta- and CD4+8- TCR alpha beta- cells. After GC treatment, we observed significant increases in the percentages of CD4-8+ TCR alpha beta- and CD4+8- TCR alpha beta- cells. The extent of the increase in the percentage of CD4-8+ TCR alpha beta- cells was greater than that of CD4+8- TCR alpha beta- thymocytes. Two-color analysis of TCR alpha beta and major histocompatibility complex (MHC) class I antigen showed that GC treatment significantly increased the percentage of TCR alpha beta- MHC class Ihi cells. Three-color analysis of CD4, CD8 and MHC class I demonstrated that normal rat thymocytes contain CD4-8- MHC class Ihi cells, which increased in number after GC treatment. These results indicate that rat thymocytes contain no fewer CD4-8+ TCR alpha beta- and CD4+8- TCR alpha beta+ cells than do mouse thymocytes, and that CD4-8+ TCR alpha beta- cells predominate over CD4+8- TCR alpha beta- cells in LEW rat thymus. Rat CD4-8- cells seemed to be divided into two subsets of TCR alpha beta- MHC class Ihi and TCR alpha beta- MHC class I- cells.
Transplantation Proceedings | 1998
Masafumi Yamauchi; Masahiro Tsuchida; M Konishi; Kimio Takai; Katsusuke Naito; Tetsuo Fukumoto
THYMOCYTES are divided into four major populations: CD4CD8, CD4CD8, CD4CD8, and CD4CD8 thymocytes. Immature thymocytes develop into mature thymocytes through the expression of T cell receptors (TCR). These developmental sequences in phenotypic and TCR expression are considered important for the production of mature thymocytes. FK506 or Tacrolimus, which is a macrolide antibiotic produced by Streptomyces tsukubaensis, is a strong immunosuppressant drug that has been widely used for renal and other organ transplantations. In several studies it has been observed that FK506 also affects the thymus in rodent models. We have analyzed and reported the effects of FK506 on rat thymocytes using immunohistochemical stainingand 3–color flow cytofluorometry. In this study we also investigated and presented the effects of FK506 on rat thymic tissues analyzing the vascular structures in the thymus.
Journal of Pharmacy and Pharmacology | 1997
Masahiko Takemoto; Masahiro Tsuchida; M Konishi; Akinobu Suga; Kazutaka Jojima; Katsusuke Naito
The oral adsorbent AST‐120 is used to inhibit the progression of renal failure by adsorbing uraemic toxins in the gastrointestinal tract. When AST‐120 is administered to patients receiving immunosuppressive medicines, it is important to study the effect of AST‐120 on the amount of these and other drugs absorbed. We have, therefore, studied the in‐vitro adsorption of cyclosporin by AST‐120 and investigated the effect of oral administration of AST‐120 on the absorption of cyclosporin in rats.
Transplantation Proceedings | 2000
Koki Fujikawa; Kimio Takai; T Hiragino; Masafumi Yamauchi; M Konishi; Akihiko Aoki; Akinobu Suga; Katsusuke Naito
FK506 is an immunosuppressive agent that was discovered in Japan. Many experiments on organ transplantation have shown the prolongation of allograft survival in animals by treatment with FK506. Previous studies have also shown that FK506 has a remarkable immunosuppressive effect and improves the outcome of liver transplantation. We recently analyzed the effect of FK506 on thymocyte differentiation by the immunoperoxidase technique and flow cytometry using monoclonal antibodies (MoAbs) for thymus and T-cell surface antigens, and we found a reduction of major histocompatibility complex (MHC) class II antigen expression on thymic epithelial cells. Our results have suggested that FK506 inhibited thymocyte differentiation in rats by not only directly but also by indirectly acting on thymic epithelial cells. In the present study, we investigated the effect of FK506 on rat thymic epithelial cells by immunohistochemistry using various MoAbs.
Archives of Histology and Cytology | 1997
Yoshihisa Fujikura; Yu-Hsueh Wang; Masahiro Tsuchida; Yukio Ohba; M Konishi; Masafumi Yamauchi; Hidefumi Kawamura; Tomoo Sawada; Nobuko Tokuda; Min-Kyu Choi; Katsusuke Naito; Tetsuo Fukumoto
International Journal of Clinical Oncology | 2013
Tomoyuki Shimabukuro; Shigeru Sakano; Kenji Matsuda; Yoriaki Kamiryo; Norio Yamamoto; Yoshitaka Kaneda; Takahito Nasu; Yoshikazu Baba; Akinobu Suga; Mitsutaka Yamamoto; Akihiko Aoki; Kimio Takai; Satoru Yoshihiro; M Konishi; Katsuhiko Imoto; Hideyasu Matsuyama
International Journal of Clinical Oncology | 2016
Takahiko Hara; Hideyasu Matsuyama; Yoriaki Kamiryo; Shigeaki Hayashida; Norio Yamamoto; Takahito Nasu; Keiji Joko; Yoshikazu Baba; Akinobu Suga; Mitsutaka Yamamoto; Akihiko Aoki; Kimio Takai; Satoru Yoshihiro; M Konishi; Sigeru Sakano; Katsuhiko Imoto; Yasuhide Tei; Shiro Yamaguchi; Seiji Yano
Transplantation Proceedings | 2000
Kimio Takai; Kei Shiraishi; Koki Fujikawa; T Hiragino; M Konishi; Akihiko Aoki; Akinobu Suga; Masanori Fujimoto; Kazuyuki Nakamura; Katsusuke Naito
Transplantation Proceedings | 2003
Hidefumi Kawamura; Masafumi Matsumura; Y Kishi; Koki Fujikawa; Koichi Uchiyama; Masahiro Tsuchida; M Konishi; Kimio Takai; Akihiko Aoki; Akinobu Suga; Katsusuke Naito
Transplantation Proceedings | 2000
Kimio Takai; Koki Fujikawa; T Hiragino; M Konishi; Akihiko Aoki; Akinobu Suga; Katsusuke Naito